Role of the endogenous cannabinoid system in nicotine addiction: novel insights

Role of the endogenous cannabinoid system in nicotine addiction: novel insights

Several lines of evidence have shown that the endogenous cannabinoids are implicated in several neuropsychiatric diseases. Notably, preclinical and human clinical studies have shown a pivotal role of the cannabinoid system in nicotine addiction. The CB1 receptor inverse agonist/antagonist rimonabant...

Full description

Bibliographic Details
Main Authors:	Islam Hany Gamaleddin, Jose M. Trigo, Aliou eGueye, Alexander eZvonok, Alexandros eMakriyannis, Steven eGoldberg, Bernard eLe Foll
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-03-01
Series:	Frontiers in Psychiatry
Subjects:	Neurotransmitter Uptake Inhibitors Nicotine Addiction Cannbinoid system Endogenous cannbinoids
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fpsyt.2015.00041/full

Similar Items

P.29 Involvement of Cannabinoid Receptors in Regulation of MMPs, Cell Proliferation and Apoptosis in Vascular Smooth Muscle Cells
by: Bettina Greiner, et al.
Published: (2020-12-01)

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking.
by: Islam Gamaleddin, et al.
Published: (2012-01-01)

Recent Methods for Measuring Dopamine D3 receptor Occupancy In Vivo: Importance for Drug Development
by: Bernard eLe Foll, et al.
Published: (2014-07-01)

High reinforcing efficacy of nicotine in non-human primates.
by: Bernard Le Foll, et al.
Published: (2007-02-01)

Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences
by: Justin Matheson, et al.
Published: (2023-03-01)

Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health
by: Justin Matheson, et al.
Published: (2020-09-01)

Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System
by: Bernard Le Foll, et al.
Published: (2018-10-01)

Transcriptomic Characterization of the Human Insular Cortex and Claustrum
by: Christine Ibrahim, et al.
Published: (2019-11-01)

The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience
by: Dafna Sara Rubin-Kahana, et al.
Published: (2022-09-01)

Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol
by: Christine Ibrahim, et al.
Published: (2022-09-01)

Long-term consequences of adolescent cannabinoid exposure in adult psychopathology
by: Justine eRenard, et al.
Published: (2014-11-01)

Monitoring the impact of cannabis use
by: Bernard Le Foll
Published: (2022-07-01)

Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies
by: Philippe eLe Bouteiller, et al.
Published: (2013-11-01)

The Insula: A Brain Stimulation Target for the Treatment of Addiction
by: Christine Ibrahim, et al.
Published: (2019-07-01)

Neurotransmitter regulation of neural development: acetylcholine and nicotinic receptors
by: TORRÃO ANDRÉA S., et al.
Published: (2002-01-01)

Non-Small Cell Lung Cancer : The challenges of the next decade
by: Thierry eLe Chevalier, et al.
Published: (2011-09-01)

Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample
by: Zoe Bourgault, et al.
Published: (2022-01-01)

Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample
by: Dafna Sara Rubin-Kahana, et al.
Published: (2022-04-01)

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
by: Thomas Murphy, et al.
Published: (2020-06-01)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
by: Justin Matheson, et al.
Published: (2020-05-01)

Psychosocial and pharmacological interventions for the treatment of cannabis use disorder [version 1; referees: 3 approved]
by: Pamela Sabioni, et al.
Published: (2018-02-01)

Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis
by: Thomas Murphy, et al.
Published: (2021-07-01)

Targeting the Endoplasmic Reticulum Stress-Linked PERK/GRP78/CHOP Pathway with Magnesium Sulfate Attenuates Chronic-Restraint-Stress-Induced Depression-like Neuropathology in Rats
by: Hany H. Arab, et al.
Published: (2023-02-01)

Pharmacokinetic and pharmacodynamic studies of nicotine in rat brain: a simultaneous investigation of nicotine metabolites and the release of neurotransmitters in vivo
by: Lulu Guo, et al.
Published: (2023-10-01)

Serotonin enhances solitariness in phase transition of the migratory locust
by: Xiaojiao eGuo, et al.
Published: (2013-10-01)

Distribution of the a2, a3, and a5 nicotinic acetylcholine receptor subunits in the chick brain
by: Torrão A.S., et al.
Published: (1997-01-01)

Frequent occurrence of nicotinic acetylcholine receptors in GABAergic neurons of the chick visual system
by: A.S. Torrão, et al.
Published: (2001-10-01)

Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.
by: Patricia Di Ciano, et al.
Published: (2016-01-01)

No metaphorical timeline in gesture and cognition among Yucatec Mayas
by: Olivier eLe Guen, et al.
Published: (2012-08-01)

A Neurochemical and Electrophysiological Study on the Combined Effects of Caffeine and Nicotine in the Cortex of Rats
by: Iman M. Mourad, et al.
Published: (2021-09-01)

Two dopamine receptors play different roles in phase change of the migratory locust
by: Xiaojiao eGuo, et al.
Published: (2015-03-01)

DETERMINATION OF GAMMA - AMINOBUTYRIC ACID BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
by: D. Qujeq
Published: (1998-08-01)

Neurobiology of DOPA as a neurotransmitter /
by: Misu, Yoshimi, 1934-, et al.
Published: (2006)

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
by: Raluca Ioana Teleanu, et al.
Published: (2022-05-01)

Interactions between the Nicotinic and Endocannabinoid Receptors at the Plasma Membrane
by: Ana Sofía Vallés, et al.
Published: (2022-08-01)

Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
by: Justin Matheson, et al.
Published: (2022-10-01)

Comparative studies between mice molars and incisors are required to draw an overview of enamel structural complexity
by: MICHEL eGOLDBERG
Published: (2014-09-01)

Metabolic flux and compartmentation analysis in the brain in vivo
by: Bernard eLanz, et al.
Published: (2013-10-01)

Pharmacokinetic Properties of the Novel Synthetic Cannabinoid 5F-APINAC and Its Influence on Metabolites Associated with Neurotransmission in Rabbit Plasma
by: Ksenia M. Shestakova, et al.
Published: (2021-07-01)

Visual Field Preferences of Object Analysis for Grasping with One Hand
by: Ada eLe, et al.
Published: (2014-10-01)